Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Large Decrease in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 4,700 shares, a decline of 66.2% from the October 15th total of 13,900 shares. Based on an average trading volume of 34,800 shares, the short-interest ratio is currently 0.1 days.

Revolution Medicines Stock Performance

Shares of RVMDW traded down $0.06 during trading hours on Tuesday, reaching $0.55. The company had a trading volume of 11,246 shares, compared to its average volume of 18,419. Revolution Medicines has a 12-month low of $0.03 and a 12-month high of $1.05. The firm has a 50 day simple moving average of $0.18 and a 200-day simple moving average of $0.17.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.